Hypertrophic Cardiomyopathy Clinical Trial

Hypertrophic Cardiomyopathy Pilot Study

Summary

This study evaluates mechanisms of arrhythmogenicity in hypertrophic cardiomyopathy, in comparison to patients with well-understood arrhythmogenic substrate (ischemic cardiomyopathy), as well as to individuals free from arrhythmogenic substrate

View Eligibility Criteria

Eligibility Criteria

Inclusion Criteria:

Diagnosed HCM
Documented history of sustained ventricular tachyarrhythmia or resuscitated sudden cardiac arrest
Maximal left ventricular wall thickness of > 30mm
Extensive fibrosis on cardiac MRI (>15% of total myocardial volume)
>7.5%/5-year risk of sudden cardiac death as determined by HCM risk-SCD

Exclusion Criteria:

age < 18 years
Pregnancy
Atrial Fibrillation

Study is for people with:

Hypertrophic Cardiomyopathy

Estimated Enrollment:

40

Study ID:

NCT02806479

Recruitment Status:

Completed

Sponsor:

Oregon Health and Science University

Check Your Eligibility

Let’s see if you might be eligible for this study.

What is your age and gender ?

Submit

There is 1 Location for this study

See Locations Near You

Oregon Health and Science University
Portland Oregon, 97239, United States

How clear is this clinincal trial information?

Study is for people with:

Hypertrophic Cardiomyopathy

Estimated Enrollment:

40

Study ID:

NCT02806479

Recruitment Status:

Completed

Sponsor:


Oregon Health and Science University

How clear is this clinincal trial information?

×

Introducing, the Journey Bar

Use this bar to access information about the steps in your cancer journey.

Please confirm you are a US based health care provider:

Yes, I am a health care Provider No, I am not a health care provider